Correction To: GLP-1RAs in Type 2 Diabetes: Mechanisms That Underlie Cardiovascular Effects and Overview of Cardiovascular Outcome Data

Cardiovascular Diabetology- United Kingdom

doi 10.1186/s12933-019-0825-1

Full Text

Abstract

Available in

Categories

Internal Medicine

Cardiovascular Medicine

Date

March 1, 2019

Authors

Andrei C. Sposito

Otávio Berwanger

Luiz Sérgio F. de Carvalho

José Francisco Kerr Saraiva

Publisher

Springer Science and Business Media LLC

Related search

Lessons From a Cardiovascular Outcome Trial With Liraglutide in Type 2 Diabetes

Journal of Diabetes Investigation

Internal Medicine

English

Managing Cardiovascular Risk in Type 2 Diabetes: What Do the Cardiovascular Outcome Trials Mean for Australian Practice?

Diabetes Therapy

Internal Medicine

English

Type 2 Diabetes and Cardiovascular Risk Factors

Current Medical Research and Opinion

English

Postprandial Dysmetabolism and Cardiovascular Disease in Type 2 Diabetes

Postgraduate Medical Journal

English

Cardiovascular Risk in Patients With Type 2 Diabetes

English

Molecular Clocks, Type 2 Diabetes and Cardiovascular Disease

Diabetes and Vascular Disease Research

Internal Medicine

Cardiovascular Medicine

English

Sulfonylureas and Cardiovascular Complications of Type 2 Diabetes Mellitus

Diabetes Mellitus

Internal Medicine

English

Contribution of Non Traditional Cardiovascular Risk Factors to the Cardiovascular Disease in Patient With Type 2 Diabetes

Zagazig University Medical Journal

English

Dapagliflozin: Cardiovascular Safety and Benefits in Type 2 Diabetes Mellitus

English